Haryana Residence Minister Anil Vij, who had examined constructive for Covid-19 on December 5, was on Wednesday discharged from Medanta Hospital. The 67-year-old will now keep at his Ambala residence on oxygen help, he mentioned in a tweet.
Over the previous few days, Vij had been exhibiting regular enchancment. Initially, the BJP chief was admitted to the Civil Hospital at Ambala and later shifted to the PGIMS, Rohtak, earlier than being hospitalised at Medanta. A medical bulletin by PGIMS mentioned that Vij had “average Covid-19 with bilateral viral pneumonia”.
I’m discharged from Medanta Hospital right now. Will keep at Residence on Oxygen help.
— ANIL VIJ MINISTER HARYANA (@anilvijminister) December 30, 2020
The minister had final month acquired one shot of the two-dose trial of the Covid-19 vaccine Covaxin after he supplied to be a volunteer. The senior BJP chief had supplied to be the primary volunteer within the part three trials for Covaxin, an indigenous potential vaccine being developed by Bharat Biotech.
He was administered the dose on November 20 on the Civil Hospital in Ambala Cantonment, about 50 km from Chandigarh. Earlier than he may obtain the second dose, he examined constructive for Covid-19.
Covaxin has been designed to be protecting two weeks after volunteers obtain the second dose.
The Union well being ministry had additionally stepped in to say that Covaxin is a two-dose anti-coronavirus vaccine and that Vij was given solely the primary dose a fortnight earlier than he examined constructive.
“The antibodies in opposition to the an infection construct up in a human being solely after a selected variety of days move after the second dose of the vaccine is taken. This can be a two-dose vaccine. The minister in query has taken just one dose of the vaccine,” the ministry had mentioned in an announcement.
Vij had earlier mentioned that he had gone to Panipat a couple of days previous to testing constructive for coronavirus the place he spent two to 3 hours with a BJP chief, who too examined constructive for COVID-19.